MX2018011811A - Apositos para heridas modificados. - Google Patents

Apositos para heridas modificados.

Info

Publication number
MX2018011811A
MX2018011811A MX2018011811A MX2018011811A MX2018011811A MX 2018011811 A MX2018011811 A MX 2018011811A MX 2018011811 A MX2018011811 A MX 2018011811A MX 2018011811 A MX2018011811 A MX 2018011811A MX 2018011811 A MX2018011811 A MX 2018011811A
Authority
MX
Mexico
Prior art keywords
wounds
chronic
compositions
kits
compounds
Prior art date
Application number
MX2018011811A
Other languages
English (en)
Inventor
Ballamy Lucy
Original Assignee
Convatec Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convatec Technologies Inc filed Critical Convatec Technologies Inc
Publication of MX2018011811A publication Critical patent/MX2018011811A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0073—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form semi-solid, gel, hydrogel, ointment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/56—Wetness-indicators or colourants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/442—Colorants, dyes

Abstract

Las modalidades descritas en la presente se refieren a compuestos para la detección de heridas, por ejemplo, heridas crónicas o heridas infectadas, que incluyen composiciones, sustratos, kits, materiales de apósitos y artículos, y sistemas que contengan los compuestos. Modalidades adicionales se refieren a métodos de uso de estas composiciones, kits y sistemas en ensayos de diagnóstico, y en el diagnóstico y/o detección de heridas crónicas o infectadas en función de la conversión enzimática de sustratos específicos que están contenidos en las composiciones. Modalidades adicionales se refieren a métodos de caracterización de heridas en función de la expresión de una pluralidad de marcadores y de uso de la información para tratar y controlar pacientes que padecen heridas crónicas o infectadas, y para hacerles seguimiento.
MX2018011811A 2016-03-30 2017-03-30 Apositos para heridas modificados. MX2018011811A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662315567P 2016-03-30 2016-03-30
PCT/US2017/024915 WO2017173026A1 (en) 2016-03-30 2017-03-30 Modified wound dressings

Publications (1)

Publication Number Publication Date
MX2018011811A true MX2018011811A (es) 2019-08-21

Family

ID=59965163

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011811A MX2018011811A (es) 2016-03-30 2017-03-30 Apositos para heridas modificados.

Country Status (19)

Country Link
US (3) US20190307904A1 (es)
EP (1) EP3436012B1 (es)
JP (2) JP7394526B2 (es)
KR (1) KR20180132093A (es)
CN (1) CN109219436A (es)
AR (1) AR108054A1 (es)
AU (1) AU2017244116C1 (es)
BR (1) BR112018070191A2 (es)
CA (1) CA3019548A1 (es)
CL (1) CL2018002782A1 (es)
CO (1) CO2018011720A2 (es)
EC (1) ECSP18081922A (es)
IL (1) IL262011A (es)
MX (1) MX2018011811A (es)
PL (1) PL3436012T3 (es)
SG (1) SG11201808528VA (es)
TW (1) TW201806625A (es)
UY (1) UY37176A (es)
WO (1) WO2017173026A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
AU2017243601A1 (en) 2016-03-30 2018-11-22 Acib Gmbh Detecting microbial infection in wounds
MX2018011811A (es) 2016-03-30 2019-08-21 Convatec Technologies Inc Apositos para heridas modificados.
HRP20221427T1 (hr) 2017-10-06 2023-01-06 Eluciderm Inc. Kompozicije i postupci za liječenje rana
US11491042B2 (en) 2017-11-09 2022-11-08 11 Health And Technologies Limited Ostomy monitoring system and method
JP2022506749A (ja) * 2018-11-02 2022-01-17 ファウント バイオ， インコーポレイテッド 架橋される材料
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
EP4031112A4 (en) * 2019-09-19 2023-10-11 Ohio State Innovation Foundation TRANSFECTION PLATFORMS BASED ON NANOFIBRE AND NANOWHISKER
WO2021087008A1 (en) * 2019-10-28 2021-05-06 Brown University Bacterial beta-lactamase responsive hydrogels
EP4057908A4 (en) * 2019-11-14 2023-11-22 Bruin Biometrics, LLC ULTRASONIC IMAGING
CN111012944A (zh) * 2019-12-30 2020-04-17 山东星之诚生物科技有限公司 一种基于藻酸盐和透明质酸的液体敷料及其制备方法
CN111330069A (zh) * 2020-03-09 2020-06-26 蔡钧 一种外用敷料及其制备方法和应用
CN112358646B (zh) * 2020-10-20 2023-03-31 湖北大学 一种荧光水凝胶敷料的制备方法及其应用
CN112341638B (zh) * 2020-11-05 2022-07-15 云南师范大学 一种多孔结构水凝胶材料及其制备与应用
CN112370567B (zh) * 2020-11-19 2023-05-16 南方医科大学南方医院 一种具有抗菌消炎功能的水凝胶活性敷料
CN112980003B (zh) * 2021-04-16 2022-06-28 中国药科大学 一种基于天然多糖型抗菌水凝胶、制备方法及用途
CN114470297B (zh) * 2021-12-20 2022-09-13 山西医科大学 一种糖触发响应型创伤快愈型敷料及其制备方法
CN114835722B (zh) * 2022-05-12 2023-03-21 大连理工大学 一种用于测定农药残留的丙氨酸氨基肽酶荧光探针的合成与应用
CN115920119A (zh) * 2022-11-18 2023-04-07 常州大学 明胶酶响应性光热载氧水凝胶伤口敷料及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
DE3783073T2 (de) * 1986-04-22 1993-04-29 Ajinomoto Kk Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen.
WO1993004192A1 (en) * 1991-08-23 1993-03-04 Molecular Probes, Inc. Use of haloalkyl derivatives of reporter molecules to analyze metabolic activity in cells
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
GB2381452B (en) 2001-11-05 2005-08-10 Johnson & Johnson Medical Ltd Wound monitoring
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US7544640B2 (en) 2002-12-10 2009-06-09 Halliburton Energy Services, Inc. Zeolite-containing treating fluid
CA2511205C (en) * 2002-12-26 2009-07-14 Otsuka Chemical Co., Ltd. Sugar-chain asparagine derivatives and processes for the preparation thereof
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
JP4490290B2 (ja) 2002-12-31 2010-06-23 ネクター セラピューティクス アラバマ，コーポレイション 加水分解安定性マレイミド末端ポリマー
WO2006080951A2 (en) * 2004-07-01 2006-08-03 Yale University Targeted and high density drug loaded polymeric materials
EP2007360B1 (en) 2006-04-03 2014-11-26 Isa Odidi Controlled release delivery device comprising an organosol coat
PT2433138T (pt) 2009-05-18 2016-12-19 Technische Universität Graz Método para detectar infecções numa ferida
CA2793354C (en) 2010-04-07 2016-06-21 Comvita New Zealand Limited Gel composition
GB201012333D0 (en) 2010-07-22 2010-09-08 Convatec Technologies Inc Fibres, a process for producing such fibres and a wound dressing incorporating them
GB201020193D0 (en) * 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan compositions
WO2012074509A1 (en) 2010-11-30 2012-06-07 Avery Dennison Corporation Sensing patch applications
US9932622B2 (en) * 2011-01-31 2018-04-03 Woundchek Laboratories B.V. Wound prognosis
FR2977491B1 (fr) 2011-07-05 2013-07-26 Melvita Production Composition cosmetique comprenant un melange de miels
US20120183585A1 (en) * 2012-02-25 2012-07-19 Rassoul Dinarvand Gel based wound dressing and a method of synthesizing the same
US9139718B2 (en) * 2012-12-20 2015-09-22 E I Du Pont De Nemours And Company Preparation of poly alpha-1,3-glucan ethers
KR20150119848A (ko) 2012-12-21 2015-10-26 바이오얼라이언스 씨.브이. 친수성 자기-희생 링커 및 그것의 포합체
US11433092B2 (en) * 2013-03-15 2022-09-06 Synedgen, Inc. Compositions and methods of use for wound healing
AU2014247614B2 (en) 2013-03-30 2017-09-21 Glytech, Inc. (sugar chain)-polypeptide complex
US20150143467A1 (en) 2013-11-19 2015-05-21 Intel-Ge Care Innovations Llc System and method for facilitating communication between a web application and a local peripheral device through a native service
EP3662876B1 (en) 2016-03-01 2023-03-01 3M Innovative Properties Company Drape for use with medical therapy systems
MX2018011811A (es) 2016-03-30 2019-08-21 Convatec Technologies Inc Apositos para heridas modificados.
TW201800069A (zh) 2016-03-30 2018-01-01 康華特科技有限公司 傷口中微生物感染檢測方法

Also Published As

Publication number Publication date
US20240123091A1 (en) 2024-04-18
WO2017173026A1 (en) 2017-10-05
BR112018070191A2 (pt) 2019-01-29
JP7395630B2 (ja) 2023-12-11
CA3019548A1 (en) 2017-10-05
AR108054A1 (es) 2018-07-11
IL262011A (en) 2018-10-31
US20190307904A1 (en) 2019-10-10
JP2022065128A (ja) 2022-04-26
PL3436012T3 (pl) 2024-04-08
EP3436012A1 (en) 2019-02-06
AU2017244116A1 (en) 2018-11-15
KR20180132093A (ko) 2018-12-11
EP3436012A4 (en) 2019-10-23
JP2019509853A (ja) 2019-04-11
EP3436012B1 (en) 2023-09-20
EP3436012C0 (en) 2023-09-20
UY37176A (es) 2017-10-31
ECSP18081922A (es) 2019-02-28
CN109219436A (zh) 2019-01-15
JP7394526B2 (ja) 2023-12-08
AU2017244116B2 (en) 2023-03-02
TW201806625A (zh) 2018-03-01
CL2018002782A1 (es) 2019-03-15
AU2017244116C1 (en) 2023-06-01
US20210275693A1 (en) 2021-09-09
JP7395630B6 (ja) 2024-01-23
SG11201808528VA (en) 2018-10-30
US11865192B2 (en) 2024-01-09
CO2018011720A2 (es) 2018-11-13

Similar Documents

Publication Publication Date Title
MX2018011811A (es) Apositos para heridas modificados.
AU2017243601A1 (en) Detecting microbial infection in wounds
ZA202100676B (en) Anti-tigit antibody and uses thereof
EP3693034B8 (en) Systems for the treatment of wounds with dressing having closed cells
MX2016015511A (es) Compuestos que comprenden grupo auto-destructivo.
BR112018006080A2 (pt) novos compostos bicíclicos como inibidores de dupla ação de atx/ca
BR112015032595A2 (pt) inibidores de ido
BR112018075288A2 (pt) métodos para diagnóstico de infecções bacterianas e virais
BR112016028255A2 (pt) agentes imunorreguladores
DOP2013000216A (es) Modulacion de la expresion del transductor de señales y activador de la transcripcion 3 (stat3)
BR112018006034A2 (pt) compostos bicíclicos como inibidores de atx
GEP20227406B (en) Chromane monobactam compounds for the treatment of bacterial infections
BR112016002845A2 (pt) composições e métodos para tratar condições associadas ao complemento
BR112014028991A2 (pt) triazóis como inibidores de kv3
BR112018005114A2 (pt) um novo polipeptídeo de endolisina
WO2018136919A3 (en) Methods relating to lung cancer
BR112018012177A2 (pt) ?moduladores de hidantação de canais kv 3?
AU2015275507A8 (en) Cyclic dipeptide-containing composition
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
SG10201407036YA (en) Markers of Endothelial Progenitor Cells and Uses Thereof
WO2015112895A3 (en) Antibody specific to staphylococcus aureus, therapeutic method and detection method using same
TW201613982A (en) Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
WO2015158890A3 (en) Pancreatic cancer therapy and diagnosis
BR112014019704A8 (pt) Compostos inibidores de hsp90 c-terminais, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou prevenção de um distúrbio neurodegenerativo
BR112015028997A2 (pt) biomarcadores de expressão gênica e seu uso para a aplicação diagnóstica e prognóstica em pacientes potencialmente com necessidade de tratamento de inibidor de hdac